Peptide dual agonists of GIPR and GLP2R

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11725037
APP PUB NO 20200392198A1
SERIAL NO

17007407

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herewith are peptide dual agonists of at least the GIPR (glucose-dependent insulinotropic polypeptide receptor) and the GLP2R (glucagon-like peptide-2 receptor), and their use for treatment of bone disorders such as osteoporosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • UNIVERSITY OF COPENHAGEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gabe, Maria Buur Nordskov Værløse, DK 4 1
Gasbjerg, Lærke Smidt Vanløse, DK 5 2
Hartmann, Bolette Hellerup, DK 4 2
Holst, Jens Juul Hellerup, DK 14 197
Rosenkilde, Mette Marie Hellerup, DK 13 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 15, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 15, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 15, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00